Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings and revenues for Lundin Mining in the upcoming earnings report, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Lundin Mining is expected to report quarterly earnings of $0.10 per share, reflecting a 37.5% decrease year-over-year, and revenues are projected at $843.02 million, down 22.2% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised 31.67% higher in the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative Earnings ESP reading can indicate the likely deviation from consensus estimates, with a positive reading being a strong predictor of an earnings beat [9][10]. Current Earnings ESP and Zacks Rank - For Lundin, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -10.73%, and the stock holds a Zacks Rank of 3, complicating predictions for an earnings beat [12]. Historical Performance - Lundin has not exceeded consensus EPS estimates in the last four quarters, with the last reported quarter matching expectations with earnings of $0.11 per share [13][14]. Market Reaction Factors - An earnings beat or miss may not solely dictate stock movement, as other factors can influence investor sentiment [15].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for CF Industries despite higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. CF Industries Summary - Expected quarterly earnings for CF Industries are $2.28 per share, reflecting a year-over-year decrease of 0.9% [3]. - Projected revenues are $1.73 billion, representing a 10.3% increase from the previous year [3]. - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - The Most Accurate Estimate for CF is higher than the consensus, resulting in an Earnings ESP of +10.03%, suggesting a likely earnings beat [11]. - CF has a history of surpassing consensus EPS estimates, achieving this in the last four quarters, with a notable surprise of +25.85% in the last reported quarter [12][13]. Industry Context - In the Zacks Fertilizers industry, Mosaic is expected to report earnings of $0.67 per share, indicating a year-over-year increase of 24.1% [17]. - Mosaic's projected revenue is $3.13 billion, up 11.1% from the previous year [17]. - Mosaic also has an Earnings ESP of +10.45%, suggesting a likely earnings beat, although it has only surpassed EPS estimates once in the last four quarters [18].

Core Viewpoint - The market anticipates BrightView Holdings (BV) to report a year-over-year increase in earnings despite lower revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus EPS estimate for BrightView is $0.33 per share, reflecting a year-over-year increase of +3.1%, while revenues are projected to be $723.5 million, a decrease of 2.1% from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 5.22% higher, indicating a collective reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for BrightView is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -0.75%, suggesting a bearish outlook from analysts [12]. Historical Performance - In the last reported quarter, BrightView exceeded the expected earnings of $0.12 per share by delivering $0.14, resulting in a surprise of +16.67%. Over the past four quarters, the company has beaten consensus EPS estimates two times [13][14]. Investment Considerations - Despite the potential for an earnings beat, BrightView does not appear to be a compelling candidate for such an outcome, and investors should consider other factors before making investment decisions [17].

Core Viewpoint - The market anticipates Ivanhoe Electric to report a year-over-year increase in earnings driven by higher revenues for the quarter ended June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Ivanhoe Electric is expected to report a quarterly loss of $0.16 per share, reflecting a year-over-year improvement of 59% [3]. - Revenue projections stand at $0.74 million, indicating a 37% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 29.41% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, with positive readings being more reliable [9][10]. - Ivanhoe Electric currently holds a Zacks Rank of 3, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, Ivanhoe Electric was expected to post a loss of $0.21 per share but reported a loss of $0.24, resulting in a surprise of -14.29% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Conclusion - While Ivanhoe Electric does not appear to be a strong candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [17].

The market expects Permian Resources (PR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 15.17% higher over the last 30 days to the cu ...

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Marqeta (MQ) despite higher revenues, with a focus on how actual results will compare to estimates [1] Earnings Expectations - Marqeta is expected to report a quarterly loss of $0.03 per share, reflecting a year-over-year change of -113% [3] - Revenue is projected to be $140.05 million, representing an 11.8% increase from the previous year [3] Estimate Revisions - The consensus EPS estimate has been revised 25% lower in the last 30 days, indicating a reassessment by analysts [4] - A negative Earnings ESP of -53.85% suggests analysts have become bearish on Marqeta's earnings prospects [12] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is significant mainly for positive readings [9][10] - Marqeta's current Zacks Rank is 3, making it challenging to predict an earnings beat [12] Historical Performance - In the last reported quarter, Marqeta was expected to post a loss of $0.05 per share but actually reported a loss of -$0.02, resulting in a surprise of +60.00% [13] - Over the past four quarters, Marqeta has beaten consensus EPS estimates three times [14] Conclusion - Marqeta does not appear to be a strong candidate for an earnings beat, and investors should consider other factors when making decisions regarding the stock ahead of the earnings release [17]

LGI Homes (LGIH) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on August 5. On the ...

Core Viewpoint - The market anticipates Lemonade (LMND) to report flat earnings with a quarterly loss of $0.81 per share, while revenues are expected to increase by 33.1% to $162.39 million compared to the previous year [1][3]. Earnings Report Expectations - The earnings report is scheduled for August 5, and if the results exceed expectations, the stock may rise; conversely, missing estimates could lead to a decline [2]. - Management's discussion during the earnings call will significantly influence the stock's immediate price change and future earnings expectations [2]. Estimate Revisions - The consensus EPS estimate has been revised 1.67% higher in the last 30 days, indicating a collective reassessment by analysts [4]. - The Most Accurate Estimate for Lemonade is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +2.40% [12]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10]. - Lemonade currently holds a Zacks Rank of 2, suggesting a high likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Lemonade was expected to post a loss of $0.94 per share but actually reported a loss of -$0.86, resulting in a positive surprise of +8.51% [13]. - Over the past four quarters, Lemonade has consistently beaten consensus EPS estimates [14]. Conclusion - While an earnings beat may not solely dictate stock movement, betting on stocks expected to exceed earnings expectations can enhance the odds of success [15][16]. - Lemonade is viewed as a compelling candidate for an earnings beat, but investors should consider other influencing factors before making investment decisions [17].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for Revolve Group despite higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The earnings report is expected on August 5, with a consensus EPS estimate of $0.12, reflecting a -42.9% year-over-year change, while revenues are projected at $295.37 million, a 4.6% increase from the previous year [3][4]. Estimate Revisions - The consensus EPS estimate has been revised 20.59% higher in the last 30 days, indicating a positive reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP for Revolve Group is +7.53%, suggesting a likelihood of beating the consensus EPS estimate, supported by a Zacks Rank of 2 [12]. Historical Performance - In the last reported quarter, Revolve Group exceeded the expected EPS of $0.13 by delivering $0.16, resulting in a +23.08% surprise. The company has beaten consensus EPS estimates in the last four quarters [13][14]. Industry Comparison - Columbia Sportswear, another player in the textile-apparel industry, is expected to report a loss of $0.28 per share, a -40% year-over-year change, with revenues projected at $589.48 million, a 3.4% increase [18].

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for ARS Pharmaceuticals, Inc. (SPRY) despite higher revenues, with a focus on how actual results will compare to estimates impacting stock price [1][2]. Earnings Expectations - The consensus estimate predicts a quarterly loss of $0.41 per share, reflecting a year-over-year change of -215.4% [3]. - Expected revenues are projected at $15.12 million, which represents a significant increase of 2924% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst assessments [4]. - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0%, suggesting no recent differing analyst views [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict deviations from consensus estimates, but its predictive power is stronger for positive readings [9][10]. - Stocks with a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 have historically shown a nearly 70% chance of a positive surprise [10]. Historical Performance - In the last reported quarter, ARS Pharmaceuticals was expected to post a loss of $0.35 per share and matched this expectation with no surprise [14]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [15]. Conclusion - ARS Pharmaceuticals does not appear to be a strong candidate for an earnings beat based on current estimates and historical performance, but other factors should also be considered by investors [18].